TRuE AD2 - An Efficacy and Safety Study of Ruxolitinib Cream in Adolescents and Adults With Atopic Dermatitis
Clinical trial NCT03745651 · COMPLETED
Trial details
- NCT number
- NCT03745651
- Sponsor
- Incyte Corporation
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2018-12-20
- Primary completion
- 2019-11-18
- Enrollment
- 618
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.